Menu

Dr. Tobias Peikert is a pulmonologist and critical care specialist currently working at the Mayo Clinic in Minnesota. Throughout his career, Dr. Peikert has been heavily involved in research for a number of diseases, including mesothelioma. He has helped author numerous medical studies around the rare cancer, investigating new treatments for all types of cancer, surgical reduction for epithelioid mesothelioma, particular genes that have been associated with mesothelioma, as well as investigating new modes of immunotherapy

Dr. Peikert has also held prominent roles in the efforts to research mesothelioma, previously serving as the Elected Chair of the Scientific Advisory Board of the Mesothelioma Applied Research Foundation (MARF) from 2016 – 2018, as well as acting as Chair of the Task Force’s Ethics Subcommittee IASLC Mesothelioma Task Force during the same time period.

Main Specialty: Pulmonology

Other Interests & Specialties: Lung cancer, mesothelioma, cancer immunology, immunotherapy, ANCA associated vasculitis and fibrosing mediastinitis.

Certifications, Awards & Accolades: American Board of Internal Medicine Certification in Critical Care Medicine, American Board of Internal Medicine Certification in Pulmonary Disease, V Foundation Scholar, Annenberg Career Development Award, Eagles Cancer Fellowship Award, Burgher Family Fellowship in Pulmonary Disease, former Elected Chair of the Scientific Advisory Board of the Mesothelioma Applied Research Foundation

Education & Experience:

  • Fellowship in Pulmonary and Critical Care at Mayo Clinic College of Medicine
  • Post Doctoral Fellowship in Department of Cancer Biology/ Department of Pulmonary Medicine at Cleveland Clinic Foundation
  • Residency in Internal Medicine at Cleveland Clinic Foundation
  • Medical Degree from Martin-Luther-University Halle-Wittenberg

Publications:
Neoantigenic Potential of Complex Chromosomal Rearrangements in MesotheliomaJournal of Thoracic Oncology. February 2019;14(2):276-287. doi: 10.1016/j.jtho.2018.10.001

Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research FoundationJournal of Thoracic Oncology. November 2018;13(11):1655-1667. doi: 10.1016/j.jtho.2018.08.2036

Effects of Reduction in Tumor Burden on Survival in Epithelioid Malignant Pleural MesotheliomaMayo Clinic Proceedings. August 2018;93(8):1026-1033. doi: 10.1016/j.mayocp.2018.01.032

Scientific Advances and New Frontiers in Mesothelioma TherapeuticsJournal of Thoracic Oncology. September 2018;13(9):1269-1283. doi: 10.1016/j.jtho.2018.06.011

Photo of Dr. Tobias Peikert

Get Help Contacting Dr. Tobias Peikert


    Privacy policy: All information is secure and will never be released

    TRUSTe

    Free

    Mesothelioma Treatment Guide

    Please fill in the form to request our FREE Mesothelioma Treatment Guide.
    It will be sent to you within 24 hours.

    Free Mesothelioma Treatment Guide



      Privacy policy: All information is secure and will never be released

      TRUSTe